23andMe logo

Sr. Financial Analyst - Therapeutics - 23andMe

View Company Profile
Job Title
Sr. Financial Analyst - Therapeutics
Job Location
Sunnyvale, CA
Job Description

23andMe’s FP&A team is looking for a Senior Financial Analyst, Therapeutics to join our growing organization.  In this role, you will partner with a highly cross functional drug development team (R&D, Project Management, Operations, Accounting) providing financial guidance and insights in addition to core FP&A responsibilities (budgeting/forecasting, reporting, monthly close, analytics).


Who We Are

Since 2006, 23andMe’s mission has been to help people access, understand, and benefit from the human genome. We are a group of passionate individuals pushing the boundaries of what’s possible to help turn genetic insight into better health and personal understanding.


What You'll Do

  • Responsible for FP&A reporting deliverables (monthly, quarterly, annual and BOD)
  • Prepare project budgets working with both internal & external partners
  • Responsible for month end close activities (including clinical trial accruals)
  • Prepare quarterly cost share invoices working with our collaboration partners
  • Ability to work independently with limited direction and supervision, within a complex and changing environment to drive delivery of solutions
  • Ad-hoc projects and initiatives


What You'll Bring

  • Bachelor’s degree or higher in Finance or Life Sciences required. MBA a plus
  • Biotechnology or pharma experience required. Experience supporting an R&D organization is a plus. Clinical trial accruals experience is also a plus
  • 5+ years of relevant FP&A experience
  • Excellent verbal and written communication skills with the capability to articulate complex financial information into easy-to-understand language
  • Ability to coordinate amongst various constituencies to work collaboratively
  • Strong problem solving skills
  • A continuous improvement mindset – streamlining, standardizing and automating processes and reporting requirements
  • Advanced MS Excel and PowerPoint skills

Note: This role will report to 23andMe's headquarters along the Bay Area Peninsula, however we are open to the possibility of applicants relocating (must be based within the United States).


About Us

Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. More information is available at www.23andMe.com.

At 23andMe, we value a diverse, inclusive workforce and we provide equal employment opportunity for all applicants and employees. All qualified applicants for employment will be considered without regard to an individual’s race, color, sex, gender identity, gender expression, religion, age, national origin or ancestry, citizenship, physical or mental disability, medical condition, family care status, marital status, domestic partner status, sexual orientation, genetic information, military or veteran status, or any other basis protected by federal, state or local laws.  If you are unable to submit your application because of incompatible assistive technology or a disability, please contact us at accommodations-ext@23andme.com. 23andMe will reasonably accommodate qualified individuals with disabilities to the extent required by applicable law.

Please note: 23andMe does not accept agency resumes and we are not responsible for any fees related to unsolicited resumes. Thank you.

23andMe Headquarters Location

Mountain View, CA

23andMe Company Size

Between 500 - 1,000 employees

23andMe Founded Year


23andMe Funding Rounds

  • Post Ipo Equity

    $250,000,000 USD

  • Series F

    $82,500,000 USD

  • Corporate Round

    $300,000,000 USD

  • Series F

    $250,000,000 USD

  • Grant

    $1,700,000 USD

  • Series E

    $115,000,000 USD

  • Grant

    $1,400,000 USD

  • Series D

    $50,000,000 USD

  • Series C

    $9,000,000 USD

  • Series C

    $22,220,289 USD

  • Series B

    $14,200,000 USD

  • Series B

    $13,600,000 USD

  • Series A

    $8,953,320 USD